Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
We’re backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.
In part 3 of our World Cancer Day series, we take a look at how liver cancer affects different regions across the world.
For this year’s World Cancer Day we’re looking at how the rates of 4 types of cancer vary around the world, and why.
Why is the shape of a cancer cell so important for predicting how the disease will behave? Our scientists may have an answer.
We take a look at some of our new, pioneering clinical trials.
There’s more to stopping cancer from spreading than simply cutting out chocolate, despite what the headlines say.
On Ada Lovelace Day 2016, we speak to Dr Bissan Al-Lazikani about how she is using computers to help personalise cancer treatment.